Germline testing in advanced cancer can lead to targeted treatmentJune 3, 2020Mixed TopicsBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanomaOncology
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unitMay 26, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersLung CancerMixed Topics
Low-dose erlotinib seems feasible for frail, elderly patients with NSCLCMay 26, 2020Lung CancerOncology
ASCO goes ahead online, as conference center is used as hospitalMay 11, 2020Mixed TopicsBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell Disorders
FDA approves selpercatinib for lung and thyroid RET tumorsMay 11, 2020Lung CancerHead & Neck/Thyroid Cancers
COVID-19 death rate was twice as high in cancer patients in NYC studyMay 5, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Three months of COVID-19 may mean 80,000 missed cancer diagnosesMay 4, 2020Breast CancerGenitourinary CancerLung CancerOncology
Cancer screening, monitoring down during pandemicMay 4, 2020Breast CancerGenitourinary CancerLung CancerMelanomaOncology
Excess cancer deaths predicted as care is disrupted by COVID-19May 1, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Antitumor treatment may increase risk of severe events in COVID-19 patientsMay 1, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerOncology
ASCO panel outlines cancer care challenges during COVID-19 pandemicApril 27, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
